Pharma Litigation Threatens to Limit State Drug Pricing Policy

In the Press

Katie Gudiksen
Katie GudiksenExecutive Editor

Bloomberg Law

Celine Castronuovo

January 30, 2024

Executive Editor Katie Gudiksen was mentioned in the 1/30/2024 Bloomberg Law article “Pharma Litigation Threatens to Limit State Drug Pricing Policy”

Excerpt: The latest high court ruling “may have made state legislators feel like the door was a little more open to pass legislation to regulate the sale of pharmaceuticals in the state,” said Katherine Gudiksen, executive editor of the Source on Healthcare Price and Competition, a project of the University of California College of the Law, San Francisco.

Source Sightings


Models for Enhanced Health Care Market Oversight


How Will Draft Merger Guidelines Impact Health Care Markets?


Editorial: Health Systems Performance: Market Structure, Consolidation, and Health Care Prices